Debunking Myths and Exploring Longevity with Rapamycin

This chapter delves into debunking common myths surrounding Alzheimer's disease, highlighting the multi-factorial nature of the disease and the role of inflammation and insulin resistance. It explores the potential of lifestyle changes and environmental modifications in slowing down biological aging and reversing chronic diseases, including heart disease, cancer, and Alzheimer's. The conversation also delves into the use of the drug Rapamycin, its origins, FDA approval for various conditions, and research on its potential to extend lifespan by targeting mTOR hyperfunction.